NCT04113668View on ClinicalTrials.gov

The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

November 19, 2019

Study Completion Date

November 25, 2019

Conditions
Healthy Participants
Interventions
DRUG

BMS-986165

Specified Dose on Specified Days

DRUG

diflunisal

Specified Dose on Specified Days

Trial Locations (1)

66219

PRA Health Sciences - Lenexa, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04113668 - The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants | Biotech Hunter | Biotech Hunter